France's REEV raised $9.2M in a funding round led by Newfund Heka, Polytechnique Ventures, and Irdi Capital to finalize the design of DREEVEN and prepare for FDA trials.
Feb 07, 2025•10 months ago
Amount Raised
$9.2 Million
Investors
Herve SilbertRaphael VaraneTechstarsIrdi CapitalPolytechnique VenturesNewfund Heka
Description
Toulouse-based REEV, a medtech startup, announced that it has raised $9.2M in a funding round. The funds will be utilized to finalize DREEVEN's design and conduct a clinical study at Boston University's Neuromotor Recovery Lab.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers